Unlock instant, AI-driven research and patent intelligence for your innovation.
as adenosine a 2b Receptor antagonists and melatonin mt 3 2-aminopyridine derivatives of receptor ligands
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of pyridine and fluoropyridine, applied in the field of pyridine derivatives, can solve the problems of limiting the pro-inflammatory effect of adenosine
Active Publication Date: 2020-06-26
PALOBIOFARMA SL
View PDF11 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Antagonists of this receptor would likely limit the pro-inflammatory effects of adenosine
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0262] Example 1 : 5-(pyridin-4-yl)-6-(pyrimidin-5-yl)pyridin-2-amine
[0263]
[0264] 5-Iodo-6-(pyrimidin-5-yl)pyridin-2-amine (0.53 g, 1.77 mmol) and (pyridin-4-yl)boronic acidpinacol ester (0.91 g, 4.42 mmoles), [1, 1'bis(diphenylphosphino)ferrocene]dichloropalladium(II) - complexed with dichloromethane (0.087g, 0.107mmoles), and 1,4-bis A mixture of 2M aqueous cesium carbonate solution (3.6 mL) in alkanes (14.3 mL) was heated to 110 °C and left to stir for 20 hours. The mixture was cooled and then partitioned between ethyl acetate and 1M aqueous sodium hydroxide solution. Partition the organic phase with sodiumbicarbonate and brine. dry (MgSO 4) and evaporate the final organic layer. The residue precipitated as a pale pink fine solid which was rinsed with cold diethyl ether and dried (0.286 g, 54.8%).
[0267] Example 2 : 5-(3-fluoropyridin-4-yl)-6-(pyrimidin-5-yl)pyridin-2-amine
[0268] Following the procedure described in Example 1, this product was synthesized from 6-(pyrimidin-5-yl)pyridin-2-amine and 3-fluoropyridine-4-boronic acid.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The present invention relates to as A 2B Adenosinereceptor antagonists and MT 3 Novel pyridine derivatives of formula (I) as ligands for the melatoninreceptor, processes for their preparation, pharmaceutical compositions comprising said compounds and manufacture for the treatment of 2B receptor and by inhibiting MT 3 Use in medicine for pathological conditions or diseases ameliorated by melatonin receptors such as respiratory diseases, metabolic disorders, neurological disorders and cancers:
Description
technical field [0001] The present invention relates to as A 2B Adenosine receptor antagonists and MT 3 Novel pyridine derivatives of ligands for the melatonin receptor. [0002] Other objects of the present invention are to provide a method for preparing said compound; a pharmaceutical composition comprising an effective amount of said compound; 2B receptor and by inhibiting MT 3 Use in medicine for pathological conditions or diseases which are ameliorated by melatonin receptors, such as respiratory diseases, metabolic disorders, neurological disorders and cancers. Background technique [0003] Adenosine passes through four subtypes of receptors—A 1 、A 2A 、A 2B and A 3 - adjust its function. These receptors are grouped according to their action on adenylate cyclase. A 1 and A 3 Receptors inhibit cAMP production by coupling to G proteins. A 2A and A 2B The receptor increases cAMP levels by stimulating an enzyme - adenylate cyclase - and also by coupling to G pr...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.